FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 331:614 September 1, 1994 Number 9 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

To the Editor: A randomized nutritional-intervention trial similar in scope and size to the Finnish alpha-tocopherol and beta carotene trial¹ has been completed in Linxian, China, an area with one of the world's highest rates of esophageal and stomach cancer and habitually low intake of several nutrients². We have previously reported³ that among the nearly 30,000 male and female participants, rates of mortality from cancer were significantly lower (relative risk, 0.87) among those who received daily supplementation from 1986 to 1991 with a combination of beta carotene (15 mg), alpha-tocopherol (30 mg), and selenium (50 µg). In this population, . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Qu, C.-X., Kamangar, F., Fan, J.-H., Yu, B., Sun, X.-D., Taylor, P. R., Chen, B. E., Abnet, C. C., Qiao, Y.-L., Mark, S. D., Dawsey, S. M. (2007). Chemoprevention of Primary Liver Cancer: A Randomized, Double-Blind Trial in Linxian, China. JNCI J Natl Cancer Inst 99: 1240-1247 [Abstract] [Full Text]  
• Albanes, D. (1999). {beta}-Carotene and lung cancer: a case study. Am. J. Clin. Nutr. 69 : 1345S-1350S [Abstract] [Full Text]